Eli Lilly & Co. Share Price
NYSE: LLYHealthcare
Live Eli Lilly & Co. Share Price Chart
O H L
Eli Lilly & Co. Performance Overview
Days Range
▼
$1169.00Low
$1206.17High
Markets Today
| Previous Close | $1,157.49 |
|---|---|
| Open | $1,173.62 |
| Volume | 1,352,262 |
| Day's Range | $1,169.00 - $1,206.17 |
| 52W Range | $783.85 - $1,292.65 |
| Market Cap | $1.02 T |
Historical Performance
| 1M Returns | +2.99 |
|---|---|
| 3M Returns | -6.32 |
| 6M Returns | +24.32 |
| 1Y Returns | +37.20 |
| 5Y Returns | +396.39 |
| 10Y Returns | +1310.03 |
Eli Lilly & Co. Fundamentals
| Market Cap | $1.02 T |
|---|---|
| Dividend yield | 0.61 |
| PE Ratio | 38.36 |
| PEG Ratio | N/A |
| Revenue | $65.18 B |
| ROE TTM | 1.01 |
| EPS TTM | $29.80 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 31.77 |
| EBITDA | $31.69 B |
| Profit Margin | 31.67 |
| Market Cap | $1.02 T |
|---|---|
| Dividend yield | 0.61 |
| PE Ratio | 38.36 |
| PEG Ratio | N/A |
| Revenue | $65.18 B |
| ROE TTM | 1.01 |
| EPS TTM | $29.80 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 31.77 |
| EBITDA | $31.69 B |
| Profit Margin | 31.67 |
Eli Lilly & Co. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $12.73 B | $15.56 B | $17.60 B | $19.29 B | $19.80 B | $22.97 B |
| Gross Profit + | $10.50 B | $13.11 B | $14.59 B | $15.92 B | $16.22 B | $19.71 B |
| Operating Income | $3.69 B | $6.87 B | $7.37 B | $8.37 B | $8.91 B | $8.98 B |
| EBITDA | $5.76 B | $7.50 B | $8.86 B | $9.57 B | $10.29 B | $12.99 B |
| Interest Expense | $0 | $249.00 M | $0 | $0 | $0 | $345.00 M |
| Depreciation | $2.07 B | $632.00 M | $1.49 B | $1.20 B | $1.37 B | $4.01 B |
| Income Before Tax | $3.46 B | $6.78 B | $7.23 B | $8.27 B | $8.85 B | $9.25 B |
| Income Tax Expense | $697.00 M | $1.12 B | $1.65 B | $1.63 B | $1.45 B | $2.15 B |
| Net Income + | $2.76 B | $5.66 B | $5.58 B | $6.64 B | $7.40 B | $7.09 B |
| Net Profit Margin | 21.67% | 36.39% | 31.72% | 34.41% | 37.36% | 30.88% |
Eli Lilly & Co. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $592.60 M | $592.00 M | $591.40 M | $590.00 M | $590.00 M | $588.00 M |
| Reserve & Surplus | $11.32 B | $13.66 B | $19.05 B | $21.59 B | $26.68 B | $29.13 B |
| Non-Current Liabilities | $43.47 B | $43.55 B | $50.94 B | $50.71 B | $48.74 B | $60.66 B |
| Current Liabilities | $30.07 B | $39.02 B | $40.14 B | $35.23 B | $36.63 B | $47.74 B |
| Total Liabilities | $73.54 B | $82.57 B | $91.08 B | $85.94 B | $85.38 B | $108.40 B |
| Fixed Assets | $24.49 B | $26.44 B | $28.76 B | $31.20 B | $33.91 B | $47.40 B |
| Current Assets | $41.26 B | $49.85 B | $62.07 B | $55.63 B | $54.84 B | $64.67 B |
| Total Assets | $89.39 B | $100.92 B | $114.94 B | $112.48 B | $116.58 B | $142.28 B |
Eli Lilly & Co. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $2.76 B | $5.66 B | $5.58 B | $6.64 B | $7.40 B | $7.09 B |
| Operating Cash Flow | $1.67 B | $3.09 B | $8.84 B | $3.22 B | $5.33 B | $10.69 B |
| Investing Cash Flow | -$3.35 B | -$1.83 B | -$2.98 B | -$2.80 B | -$3.92 B | -$15.40 B |
| Financing Cash Flow | $1.38 B | -$1.25 B | $531.00 M | -$2.88 B | -$3.47 B | $8.43 B |
| Change in Cash | -$175.00 M | $283.00 M | $6.42 B | -$2.52 B | -$1.99 B | $3.67 B |
Eli Lilly & Co. Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $469.63B | 140.54% | 75.17 | 6.92% | 2.60% |
 | $156.23B | -35.66% | 36.25 | 12.48% | 6.28% |
 | $217.86B | 92.52% | 25.03 | 20.98% | 2.50% |
 | $609.54B | 57.91% | 29.33 | 28.46% | 2.12% |
 | $3.72B | 366.01% | 0.00 | NA | 0.00% |
 | $344.27B | 73.22% | 111.45 | 28.09% | 2.44% |
 | $127.62B | 179.03% | 29.30 | 32.94% | 0.00% |
 | $33.04B | -22.55% | 39.60 | 13.07% | 0.00% |
 | $23.13B | 71.71% | 14.54 | 25.03% | 0.00% |
 | $5.77T | 1035.18% | 30.20 | 55.60% | 0.42% |
Eli Lilly & Co. Return Calculator
The Eli Lilly & Co. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$51,205
Invested Amount$10,000
Est. Returns$41,205
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Popular Stocks
FAQs
What is the share price of Eli Lilly & Co. today?
Eli Lilly & Co. (LLY) share price as of October 7, 2026 is $1194.00. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Eli Lilly & Co.?
Yes, Indian Investors can invest in the Eli Lilly & Co. (LLY) Share by opening an international trading account with Angel One.
How can I purchase Eli Lilly & Co. shares in India?
Purchasing Eli Lilly & Co. (LLY) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Eli Lilly & Co. (LLY) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Eli Lilly & Co.?
Yes, you can purchase fractional shares of Eli Lilly & Co. (LLY) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Eli Lilly & Co.?
The market capitalization of Eli Lilly & Co. on October 7, 2026, is $1.02 T.
In which sector Eli Lilly & Co. belongs?
Eli Lilly & Co. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Eli Lilly & Co. stocks?
In order to invest in Eli Lilly & Co. (LLY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
